Rice Hall James & Associates LLC lowered its holdings in Aehr Test Systems (NASDAQ:AEHR – Free Report) by 27.4% in the 3rd quarter, Holdings Channel reports. The firm owned 444,381 shares of the semiconductor company’s stock after selling 168,071 shares during the period. Rice Hall James & Associates LLC’s holdings in Aehr Test Systems were worth $13,380,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. CWM LLC raised its position in Aehr Test Systems by 15.1% in the 2nd quarter. CWM LLC now owns 6,062 shares of the semiconductor company’s stock worth $78,000 after buying an additional 793 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of Aehr Test Systems by 7.9% in the second quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock worth $201,000 after acquiring an additional 1,145 shares during the period. Osaic Holdings Inc. lifted its position in Aehr Test Systems by 1.9% during the second quarter. Osaic Holdings Inc. now owns 63,608 shares of the semiconductor company’s stock valued at $822,000 after purchasing an additional 1,210 shares during the period. Rhumbline Advisers boosted its holdings in Aehr Test Systems by 3.1% in the second quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock worth $536,000 after purchasing an additional 1,254 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Aehr Test Systems by 8.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock worth $126,000 after purchasing an additional 1,344 shares during the last quarter. 69.69% of the stock is owned by hedge funds and other institutional investors.
Aehr Test Systems Stock Performance
NASDAQ AEHR opened at $21.46 on Friday. The company has a market capitalization of $644.01 million, a PE ratio of -97.55 and a beta of 2.40. The business’s fifty day moving average is $23.39 and its 200 day moving average is $21.78. Aehr Test Systems has a fifty-two week low of $6.27 and a fifty-two week high of $34.35.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on AEHR shares. Craig Hallum lowered shares of Aehr Test Systems from a “buy” rating to a “hold” rating and set a $24.00 target price for the company. in a research note on Tuesday, October 7th. Lake Street Capital initiated coverage on Aehr Test Systems in a report on Wednesday, December 17th. They issued a “buy” rating on the stock. Weiss Ratings reissued a “sell (d)” rating on shares of Aehr Test Systems in a research report on Wednesday, October 8th. Finally, Zacks Research raised shares of Aehr Test Systems from a “strong sell” rating to a “hold” rating in a research report on Monday, December 8th. One analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Aehr Test Systems has a consensus rating of “Hold” and an average target price of $24.00.
Check Out Our Latest Stock Report on Aehr Test Systems
Insider Activity
In related news, Director Howard T. Slayen sold 6,000 shares of the stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $25.73, for a total transaction of $154,380.00. Following the completion of the transaction, the director directly owned 218,328 shares of the company’s stock, valued at approximately $5,617,579.44. This represents a 2.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Fariba Danesh sold 9,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 9th. The shares were sold at an average price of $24.79, for a total value of $223,110.00. Following the transaction, the director owned 16,643 shares of the company’s stock, valued at $412,579.97. This represents a 35.10% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 6.80% of the company’s stock.
Aehr Test Systems Company Profile
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Read More
- Five stocks we like better than Aehr Test Systems
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Do you know what Amazon is planning for January 1?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Want to see what other hedge funds are holding AEHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aehr Test Systems (NASDAQ:AEHR – Free Report).
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
